Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: an article on the 10Q
Patriot Scientific Corporation Files Quarterly Report
Last update: 10/15/2013 4:30:00 PM
CARLSBAD, Calif., Oct. 15, 2013 /PRNewswire via COMTEX/ -- Patriot Scientific Corporation (PTSC) today announced it has filed its Report on Form 10-Q with the U.S. Securities and Exchange Commission for the quarterly period ended August 31, 2013. The Report can be found on the SEC's website at .
Earlier this month Patriot announced that it had won its patent infringement lawsuit against HTC Corporation. In litigation before the United States District Court for the Northern District of California, HTC was found to infringe multiple claims within Patriot's US 5,809,336 patent. The '336 patent is one of several patents that are part of a larger portfolio held by Patriot, known as the Moore Microprocessor Patent (MMP) portfolio(TM).
In addition to Patriot's success against HTC in U.S. District Court, the MMP portfolio has survived 17 re-examination challenges before the USPTO. "We look forward to these clear validations of the MMP portfolio to have now paved the way for future licensing activity and operating returns commensurate with the portfolio's broad applicability in the digital marketplace", stated Cliff Flowers, Patriot's Interim Chief Executive Officer.
Share
New Message
Please login to post a reply